<DOC>
	<DOCNO>NCT00062621</DOCNO>
	<brief_summary>The purpose study determine whether combine bone marrow kidney transplant effective treating stage II great multiple myeloma associate kidney failure . This study determine whether transplant rejection need immunosuppressive drug decrease combined transplant approach .</brief_summary>
	<brief_title>Combined Bone Marrow Kidney Transplant Multiple Myeloma With Kidney Failure</brief_title>
	<detailed_description>In limited human testing , combine kidney bone marrow transplant appear safe effective treat multiple myeloma associate kidney failure . This study evaluate approach 10 patient kidney failure due association stage II great multiple myeloma . Treatment prior transplant include cyclophosphamide , ATGAM ( lymphocyte-specific immunosuppressant ) , local radiation thymus , cyclosporine ( immunosuppressive drug ) . An infusion donor bone marrow kidney graft closely match , relate donor transplant simultaneously . An additional infusion donor white blood cell may administer day 45 74 transplant effort eliminate remain cancer cell . Patients remain cyclosporine defined period time . The cyclosporine dose slowly decrease stop graft rejection graft-versus-host disease occur . Each participant involve study 3 year ; include intervention phase ( time initial screen approximately 7 day transplant 100 day transplant ) continue follow-up visit least 2 year follow transplant .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>Endstage renal disease ( ESRD ) due association stage II great multiple myeloma Participants development ESRD due underlie myeloma include evidence active myeloma despite past treatment standard therapy ( e.g. , prednisone , melphalan , highdose radiation therapy autologous stem cell transplantation ) On dialysis creatinine clearance great 20 ml/min HLAmatched one six HLA antigenmismatched related donor Compromised pulmonary , cardiac , liver function Active infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Immune tolerance</keyword>
	<keyword>Graft v host disease</keyword>
	<keyword>Kidney Failure</keyword>
	<keyword>Kidney disease</keyword>
	<keyword>End Stage Renal Disease</keyword>
	<keyword>Multiple Myeloma</keyword>
	<keyword>Bone Marrow Transplant</keyword>
	<keyword>Kidney Transplant</keyword>
	<keyword>Renal Transplant</keyword>
	<keyword>Tolerance</keyword>
	<keyword>Chimerism</keyword>
	<keyword>ESRD</keyword>
</DOC>